Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Enzyme-multiplied immunoassay technique (EMIT) is performed using
the Olympus analyzer. EMIT offers an alternative to the traditional
spectroscopic and chromatographic method for quantitating blood
concentrations of drugs. The technique for drugs is based upon an
enzymatic assay for glucose-6-phosphate dehydrogenase, using
spectral properties at 340 nm, in which the reduction of nicotinamide
adenine dinucleotide (NAD) substrate is monitored. The basis of the
drug detection technique is an immunological reaction between the
drug and a specific antibody. The reagent contains the enzyme
(glucose-6-phosphate dehydrogenase) to which the drug is covalently
bound and antibody-specific to the drug. The antibody binds most of
the drug-bound enzyme, rendering the enzyme inactive. This results
in a baseline enzymatic activity. In the presence of free drug, antibody
equilibrates between free drug and enzyme-bound drug leaving
some of the drug-bound enzyme uncomplexed and able to catalyze
the reaction. If more free drug is introduced, either as standard or
sample, then competition for the antibody takes place between the
drug in the sample and the drug attached to the enzyme. This results
in more drug-bound enzyme being left uncomplexed and able to
catalyze the enzyme reaction at a greater rate as compared to the
baseline activity. The observed enzyme activity increases with the
amount of total free drug in the sample. (Package insert: EMIT 2000
Valproic Acid Assay. Olympus. Melville, NY. October 2005)